Drug Type Small molecule drug |
Synonyms Prednisolone 21-(dihydrogen phosphate), Prednisolone 21-monophosphate, Prednisolone 21-phosphate + [15] |
Target |
Action agonists |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (28 May 1986), |
Regulation- |
Molecular FormulaC21H29NaO8P |
InChIKeyFZSZNUSQBKSTHL-WDCKKOMHSA-N |
CAS Registry125-02-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Edema | United States | 01 Jun 2006 | |
Endocrine System Diseases | United States | 01 Jun 2006 | |
Eye Diseases | United States | 01 Jun 2006 | |
Gastrointestinal Diseases | United States | 01 Jun 2006 | |
Hematologic Diseases | United States | 01 Jun 2006 | |
Multiple Sclerosis | United States | 01 Jun 2006 | |
Skin Diseases | United States | 01 Jun 2006 | |
Colitis, Ulcerative | Japan | 14 Mar 2002 | |
Enteritis | Japan | 14 Mar 2002 | |
Anaphylaxis | United States | 28 May 1986 | |
Neoplasms | United States | 28 May 1986 | |
Respiratory Diseases | United States | 28 May 1986 | |
Rheumatic Diseases | United States | 28 May 1986 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 3 | Netherlands | 21 Nov 2015 | |
Arteriovenous Fistula | Phase 2 | Netherlands | - | 13 Oct 2015 |
Phase 3 | - | 172 | Intravenous Pegylated Liposomal Prednisolone Sodium Phosphate 75 mg | aiwameuvsh(atdjeqveif) = qtjrdbelff lddhffauol (lirdvkxjfi ) | Positive | 12 Jun 2019 | |
Intravenous Pegylated Liposomal Prednisolone Sodium Phosphate 150 mg | aiwameuvsh(atdjeqveif) = kpwjujryha lddhffauol (lirdvkxjfi ) | ||||||
Not Applicable | - | Antibiotics and Placebo | gdmwunhylv(sjqotlqxxg) = dmkiagjvef xqelzshmkh (mgferntfyl ) View more | - | 01 May 2006 | ||
gdmwunhylv(sjqotlqxxg) = gdilahcwxf xqelzshmkh (mgferntfyl ) |